An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon.

Autor: Ateudjieu J; MA Sante, Yaoundé, Cameroon.; Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon.; Clinical Research Unit, Division of Health Operations Research, Ministry of Public Health, Cameroon., Sack DA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Nafack SS; MA Sante, Yaoundé, Cameroon., Xiao S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Tchio-Nighie KH; MA Sante, Yaoundé, Cameroon., Tchokomeni H; MA Sante, Yaoundé, Cameroon., Bita'a LB; MA Sante, Yaoundé, Cameroon., Nyibio PN; MA Sante, Yaoundé, Cameroon., Guenou E; MA Sante, Yaoundé, Cameroon., Mondung KM; MA Sante, Yaoundé, Cameroon., Dieumo FFK; MA Sante, Yaoundé, Cameroon., Ngome RM; Department of Bacteriology-Parasitology-Mycology Laboratory, Centre Pasteur of Cameroon (CPC), Yaoundé, Cameroon., Murt KN; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Ram M; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Ali M; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Debes AK; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2022 Nov 14; Vol. 107 (5), pp. 974-983. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).